Today: 1 December 2025
Subscribe
Browse Category

NYSE:NVO News 27 June 2025 - 16 August 2025

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Miracle Drugs, Mega Mergers & Outbreak Alerts – Biotech & Health News Roundup (Aug 15–16, 2025)

Wegovy (semaglutide) received FDA accelerated approval to treat metabolic dysfunction-associated steatohepatitis (MASH), becoming the first GLP-1 therapy cleared for MASH in a patient population estimated at about 5% of U.S. adults, based on part 1 of an ongoing trial showing
16 August 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Cures, Cash & Controversy: Global Biotech & Health Roundup (Aug 14–15, 2025)

Cures, Cash & Controversy: Global Biotech & Health Roundup (Aug 14–15, 2025)

Breakthroughs in Biotech & Pharma Big Deals & Industry Moves Regulatory & Health Policy Updates Public Health Developments Noteworthy Medical Research Healthcare Technology & Innovation Sources: Original news reports, press releases and scientific publications from Aug 14–15, 2025 fda.gov fiercebiotech.com
15 August 2025
 ·  ·  ·  ·  ·  ·  · 
Digital Health & Telemedicine Industry Update (June–July 2025)

Digital Health & Telemedicine Industry Update (June–July 2025)

In early June 2025, DispatchHealth and Medically Home completed a merger, forming one of the nation’s largest high-acuity hospital-at-home providers and operating under the DispatchHealth brand, integrating Medically Home’s virtual care technology and 24/7 clinical command centers. Teladoc Health signaled
3 July 2025
 ·  ·  ·  ·  ·  ·  ·  · 
The State of Artificial Intelligence in 2025: Breakthroughs, Challenges, and the Road Ahead / Updated: 2025, July 1st, 12:02 CET

The State of Artificial Intelligence in 2025: Breakthroughs, Challenges, and the Road Ahead / Updated: 2025, July 1st, 12:02 CET

Meta launched Meta Superintelligence Labs (MSL), led by Alexandr Wang and Nat Friedman, unifying all AI R&D to accelerate AGI with a multi-billion-dollar investment reportedly over $70 billion and recruiting top talent from OpenAI, Anthropic, and Google. Microsoft unveiled the
1 July 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Top Biotechnology and Health Tech Trends in 2025: Mid-Year Update and Forecast (Updated: June 27th, 2025)

Late 2024, the first FDA-approved CRISPR-based therapy exagamglogene autotemcel (Casgevy) reached patients, with Vertex reporting $2 million in revenue from this sickle-cell gene-editing therapy in Q3 2024. Prime Medicine’s PM359 autologous CRISPR prime-edited cell therapy for chronic granulomatous disease began
27 June 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
1 … 3 4 5
Go toTop